Tarsadia Capital, LLC Sage Therapeutics, Inc. Transaction History

Tarsadia Capital, LLC

  • $22.5 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 10, 2021
SELL
$58.41 - $89.06 $292,050 - $445,300
-5,000 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$41.13 - $62.45 $822,600 - $1.25 Million
-20,000 Reduced 80.0%
5,000 $306,000
Q2 2020

Aug 14, 2020
BUY
$25.95 - $43.15 $648,750 - $1.08 Million
25,000 New
25,000 $1.04 Million

Others Institutions Holding SAGE

# of Institutions
218
Shares Held
48M
Call Options Held
854K
Put Options Held
195K
View Full List

About Sage Therapeutics, Inc.

SAGE Quotes by TradingView
  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $361M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Tarsadia Capital, LLC Portfolio

Follow Tarsadia Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tarsadia Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tarsadia Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email